Treatment with the recently approved, minimally invasive Optilume BPH device improves urinary symptoms while preserving sexual function in men with benign prostatic hyperplasia (BPH), concludes a ...
Treatment with the recently approved, minimally invasive Optilume BPH device improves urinary symptoms while preserving sexual function in men with benign prostatic hyperplasia (BPH), concludes a ...
Add Yahoo as a preferred source to see more of our stories on Google. May 18—MORGANTOWN — Mon Health Medical Center achieved another first this month — becoming the first in the state to offer a novel ...
Optilume BPH is expected to have a significant global impact in urology, offering a novel alternative treatment option for enlarged prostate "We are proud at University Urology Associates to be ...
The FDA has granted approval to Urotronic Inc. for its Optilume urethral drug-coated balloon (DCB) for the treatment of male urethral strictures. The device inhibits new scar tissue growth that may ...
May 18—MORGANTOWN — Mon Health Medical Center achieved another first this month — becoming the first in the state to offer a novel, effective procedure for men with enlarged prostates. The condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results